rs111033601

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM1PM2PP3_Moderate

The NM_000517.6(HBA2):​c.207C>A​(p.Asn69Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000144 in 1,385,422 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Synonymous variant affecting the same amino acid position (i.e. N69N) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000077 ( 0 hom., cov: 21)
Exomes 𝑓: 8.0e-7 ( 0 hom. )

Consequence

HBA2
NM_000517.6 missense

Scores

1
2
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -8.51

Publications

1 publications found
Variant links:
Genes affected
HBA2 (HGNC:4824): (hemoglobin subunit alpha 2) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]
HBA2 Gene-Disease associations (from GenCC):
  • alpha thalassemia spectrum
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • erythrocytosis, familial, 7
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • hemoglobin M disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hb Bart's hydrops fetalis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hemoglobin H disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Heinz body anemia
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • methemoglobinemia, alpha type
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 5 benign, 15 uncertain in NM_000517.6
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.935

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000517.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HBA2
NM_000517.6
MANE Select
c.207C>Ap.Asn69Lys
missense
Exon 2 of 3NP_000508.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HBA2
ENST00000251595.11
TSL:1 MANE Select
c.207C>Ap.Asn69Lys
missense
Exon 2 of 3ENSP00000251595.6
HBA2
ENST00000484216.1
TSL:1
c.174C>Ap.Asn58Lys
missense
Exon 2 of 2ENSP00000495899.1
HBA2
ENST00000482565.1
TSL:1
n.343C>A
non_coding_transcript_exon
Exon 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.00000773
AC:
1
AN:
129334
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.0000364
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
7.96e-7
AC:
1
AN:
1256088
Hom.:
0
Cov.:
20
AF XY:
0.00000160
AC XY:
1
AN XY:
625918
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
24154
American (AMR)
AF:
0.00
AC:
0
AN:
36218
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24262
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35498
South Asian (SAS)
AF:
0.00
AC:
0
AN:
75482
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34478
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3714
European-Non Finnish (NFE)
AF:
0.00000103
AC:
1
AN:
969302
Other (OTH)
AF:
0.00
AC:
0
AN:
52980
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000773
AC:
1
AN:
129334
Hom.:
0
Cov.:
21
AF XY:
0.00
AC XY:
0
AN XY:
62406
show subpopulations
African (AFR)
AF:
0.0000364
AC:
1
AN:
27470
American (AMR)
AF:
0.00
AC:
0
AN:
13556
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3270
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4496
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3638
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
64410
Other (OTH)
AF:
0.00
AC:
0
AN:
1732
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Nov 04, 2019
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.010
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
0.025
DANN
Benign
0.78
DEOGEN2
Benign
0.0093
T
Eigen
Benign
-1.9
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.035
N
M_CAP
Uncertain
0.14
D
MetaRNN
Pathogenic
0.93
D
MetaSVM
Benign
-0.44
T
PhyloP100
-8.5
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-0.89
N
REVEL
Uncertain
0.38
Sift
Benign
1.0
T
Sift4G
Benign
0.56
T
Vest4
0.66
MutPred
0.95
Gain of ubiquitination at N69 (P = 0.0211)
MVP
0.96
MPC
1.4
ClinPred
0.080
T
GERP RS
-8.4
PromoterAI
-0.0080
Neutral
gMVP
0.77
Mutation Taster
=11/89
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111033601; hg19: chr16-223235; API